SNHG11 and colorectal carcinoma: Recent investigations by Fang-Ze Wei and Wei Xu have identified CLCA1 and SNHG11 as promising prognostic markers and therapeutic targets in CRC, underscoring the critical role of biomarkers in disease management (19–21).